Feng Wan
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Inhalation and Respiratory Drug Delivery 11
- Cystic Fibrosis Research Advances 3
-
- Advanced Drug Delivery Systems 10
- Drug Solubulity and Delivery Systems 4
- Co-authors
- Mingshi Yang (14 shared papers)Hanne Mørck Nielsen (10 shared papers)Camilla Foged (10 shared papers)Sylvia N. Kłodzińska (5 shared papers)Zheng Huang (4 shared papers)Jukka Rantanen (7 shared papers)María García-Díaz (1 shared paper)Ditlev Birch (1 shared paper)
In The Last Decade
Feng Wan
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 100
- Pharmaceutical Science 379
- Biomaterials 235
- Pulmonary and Respiratory Medicine 335
- Molecular Medicine 48
- Microbiology 42
Countries citing papers authored by Feng Wan
This map shows the geographic impact of Feng Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Wan more than expected).
Fields of papers citing papers by Feng Wan
This network shows the impact of papers produced by Feng Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Wan. The network helps show where Feng Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 101 | |
| 2 | 2015 | 83 | |
| 3 | 2019 | 74 | |
| 4 | 2012 | 65 | |
| 5 | 2021 | 65 | |
| 6 | 2018 | 63 | |
| 7 | 2020 | 54 | |
| 8 | 2020 | 51 | |
| 9 | 2019 | 51 | |
| 10 | 1996 | 49 | |
| 11 | 2014 | 44 | |
| 12 | 2017 | 44 | |
| 13 | 2017 | 38 | |
| 14 | 2020 | 30 | |
| 15 | 2014 | 26 | |
| 16 | 2020 | 26 | |
| 17 | 2013 | 26 | |
| 18 | 2020 | 24 | |
| 19 | 2019 | 23 | |
| 20 | 2018 | 23 |
About Feng Wan
Feng Wan is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science, Molecular Biology, Biomedical Engineering and Materials Chemistry, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (11 papers), Advanced Drug Delivery Systems (10 papers), Drug Solubulity and Delivery Systems (4 papers), Cystic Fibrosis Research Advances (3 papers), Surfactants and Colloidal Systems (2 papers), RNA Interference and Gene Delivery (2 papers), Carbon and Quantum Dots Applications (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (379 citations), Biomaterials (235 citations), Pulmonary and Respiratory Medicine (335 citations), Molecular Medicine (48 citations) and Microbiology (42 citations). Feng Wan has collaborated with scholars based in Denmark, China and Sweden. Frequent co-authors include Mingshi Yang, Hanne Mørck Nielsen, Camilla Foged, Sylvia N. Kłodzińska, Zheng Huang, Jukka Rantanen, María García-Díaz, Ditlev Birch, Morten Jonas Maltesen and Simon Bjerregaard. Their work appears in journals such as Journal of Colloid and Interface Science, ACS Applied Materials & Interfaces, Pharmaceutical Research, European Journal of Pharmaceutics and Biopharmaceutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.